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Abstract
Background: Membrane proteins (MPs) populate 20-30% of genomes sequenced to date and hold potential as
therapeutic targets as well as for practical applications in bionanotechnology. However, MP toxicity and low yields
in normally robust expression hosts such as E. coli has curtailed progress in our understanding of their structure
and function.
Results: Using the seven transmembrane segments H. turkmenica deltarhodopsin (HtdR) as a reporter, we isolated
a spontaneous mutant in the arabinose-inducible PBAD promoter leading to improved cell growth and a twofold
increase in the recovery of active HtdR at 37°C. A single transversion in a conserved region of the cyclic AMP
receptor protein binding site caused the phenotype by reducing htdR transcript levels by 65%. When the mutant
promoter was used in conjunction with a host lacking the molecular chaperone Trigger Factor (Δtig cells), toxicity
was further suppressed and the amount of correctly folded HtdR was 4-fold that present in the membranes of
control cells. More importantly, while improved growth barely compensated for the reduction in transcription rates
when another polytopic membrane protein (N. pharonis sensory rhodopsin II) was expressed under control of the
mutant promoter in wild type cells, a 4-fold increase in productivity could be achieved in a Δtig host.
Conclusions: Our system, which combines a downregulated version of the tightly repressed PBAD promoter with a
TF-deficient host may prove a valuable alternative to T7-based expression for the production of membrane
proteins that have so far remained elusive targets.
Background
Membrane proteins (MPs) play pivotal roles in a variety
of cellular functions, many of which are essential to sur-
vival [1]. Despite their physiological importance, the
study of MPs is lagging due largely to the fact that they
are difficult to express in a functional form and at levels
needed for biochemical and structural studies. Escheri-
chia coli is a popular host for MP overexpression due to
its well understood genetics and rapid growth [2]. How-
ever, as with other expression systems, high-level MP
production is typically toxic to the cell and the yields of
biologically active material are generally poor.
Based on the observation that the overexpression of
MPs in E. coli leads to their aggregation and to reduced
levels of host membrane and secretory proteins [3], it
has been suggested that MP toxicity is due to the over-
loading of the Sec-dependent translocation machinery
which handles both the post-translational export of
secretory proteins and the co-translational insertion of
most inner MP into the lipid bilayer [4]. Recently, we
have shown that eliminating the signal recognition parti-
cle (SRP) -Trigger Factor (TF) competition by making
use of TF-deficient (Δtig) expression strains can signifi-
cantly improve the accumulation of functional MP in
the bacterial inner membrane [5]. A more common
approach, however, has been to make use of E. coli C41
(DE3) and C43(DE3) [6], two BL21(DE3) derivatives
containing a mutation in the lacUV5 promoter that
decreases the production of chromosomally-encoded T7
RNA polymerase, and hence the transcription rate of
MP genes cloned downstream of the T7 promoter [7].
The same net effect can be achieved by making use of
plasmids co-expressing T7Lys (e.g. pLemo, pLysS,
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pLysE) [7,8], a T7 RNA polymerase inhibitor that
reduces the overall transcription rates of genes placed
under T7 promoter control.
In addition to being too strong for MP expression, a
drawback of the T7 promoter is its lack of tight repres-
sion in the absence of inducer, which may be proble-
matic since even basal levels of MPs can be toxic to the
cell [6,8]. The arabinose-inducible PBAD promoter of the
araBAD operon [9] is a moderately strong and tightly
repressed promoter that has been successfully used for
producing MPs in E. coli [5,10-12]. PBAD is negatively
regulated by AraC when no L-arabinose is present in
the medium, and it is positively regulated by both AraC
in the presence of arabinose and the cyclic AMP
(cAMP) receptor protein (CRP, also known as CAP, cat-
abolite gene activator protein) in the absence of glucose
[13]. When loaded with cAMP, the CRP homodimer
binds to a consensus sequence located upstream of
more than 100 E. coli promoters [14]. This binding
favors transcription initiation [15] both by bending the
DNA [16,17] and by recruiting RNA polymerase to facil-
itate its interaction with the core promoter [18].
Here, we describe the isolation of a single nucleotide
transversion in one of the CRP interaction domains of
the PBAD promoter that reduces the transcription rates
by about 70% and can improve the yields of polytopic
MPs, particularly when combined with a chaperone
pathway reprogramming strategy relying on the use of
Trigger Factor (TF) deficient mutants [5].
Results and Discussion
Isolation of a mutant PBAD expression plasmid that
alleviates HtdR toxicity
The archaeal rhodopsin Haloterrigena turkmenica del-
tarhodopsin (HtdR) is a light-driven outwards proton
pump that binds the chromophore all-trans retinal and
belongs to the G-protein coupled receptor (GPCR)
super family of 7 transmembrane (TMS) segment MPs.
Retinal-bound and properly folded HtdR confers the cell
membrane a characteristic purple color due to an
adsorption spectrum that exhibits a strong maximum at
≈ 550 nm [19]. We sought to take advantage of this
phenotype to identify E. coli mutants that were more
efficient at functional MP expression. In initial screen
design experiments, TF-deficient (Δtig) cells [20] harbor-
ing plasmid pHtdR200, a ColE1 derivative encoding a
hexahistidine-tagged version of the htdR gene under
transcriptional control of the PBAD promoter [5], were
plated onto LB agar plates supplemented with L-arabi-
nose and all-trans retinal and incubated for 36 h at 37°
C. While most colonies were small and a light shade of
red due to the toxicity of HtdR overexpression, we iso-
lated a spontaneous mutant that was both large and
purple.
To determine if the apparent increase in functional
HtdR production was associated with a mutation in the
expression vector or in the chromosomal DNA, the
plasmid was isolated, named pHtdR400, and re-trans-
formed into fresh, isogenic wild type and Δtig cells. Fig-








































Figure 1 A mutant plasmid improves the growth and viability
of cells expressing HtdR. The growth of cells harboring pHtdR200
or pHtdR400 was examined by streaking (A) or spot assays (B) on LB
agar plates supplemented with 50 μg/mL kanamycin, 100 μM of all-
trans retinal, and 0.2% L-arabinose. (C) Wild type (tig+, closed
symbols) and TF-deficient cells (Δtig, open symbols) harboring the
indicated plasmids were grown in LB-kanamycin at 37°C and HtdR
synthesis was induced by addition of 0.2% L-arabinose in mid-
exponential phase (arrow).
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confer healthy growth to both wild type and Δtig cells
that had been incubated overnight on LB-arabinose
plates. In fact, under conditions of HtdR overexpres-
sion, the viability of tig+ pHtdR400 cells was improved
by 5 orders of magnitude relative to that of pHtdR200
transformants (Figure 1B) and their specific growth
rate in liquid culture by 60% (Figure 1C, closed sym-
bols). Use of the pHtdR400 plasmid also enhanced the
fitness of Δtig mutants: viability increased 100-fold and
specific growth rates by 30% relative to control cells
(Figure 1B-C).
Impact on functional HtdR expression and productivity
We next asked if the improved growth characteristics of
pHtdR400 transformants would translate into higher
levels of target protein expression. To address this ques-
tion, the various cultures were grown to mid-exponen-
tial phase in LB medium and at 37°C, HtdR synthesis
was initiated by addition of 0.2% L-arabinose, and cells
were harvested 3 h post-induction. As expected from
our previous work [5], the use of Δtig cells led to a two-
fold increase in the amount of membrane-integrated
HtdR expressed from pHtdR200. By contrast, the overall
levels of deltarhodopsin were comparable in pHtdR200
and pHtdR400 transformants, whether or not the host
strain was wild type or tig deficient (Figure 2A). How-
ever, when the improved growth of pHtdR400 transfor-
mants was taken into account, the yield of HtdR
doubled in wild type cells. More importantly, the benefi-
cial effects of pHtdR400-driven expression and chromo-
somal TF inactivation could be combined, leading to a
more than fourfold increase in HtdR productivity
relative to tig+ pHtdR200 control cultures (Figure 2B)
and to shake flask yields as high as 20 mg/L of culture.
We took advantage of the fact that the optical signa-
ture of retinal-bound HtdR - and more specifically of its
absorption maximum at 550 nm - is a sensitive reporter
of proper folding [5,19] to estimate how much of the
protein was functional in the membranes of cells har-
vested 3 h post-induction. In very good agreement with
the results of Figure 2B, the intensity of the 550 nm
peak in tig+ pHtdR400 membrane fractions was twice
that measured in tig+ pHtdR200 samples, and there was
an about 30% increase in 550 nm absorption when
membranes from Δtig pHtdR400 cells were compared to
those from Δtig pHtdR200 cells (Figure 2C). We con-
clude that the additional deltarhodopsin produced in
pHtdR400 transformants is properly folded. (Note that
intensities at 550 nm cannot be directly compared
between tig+ and Δtig cells since TF inactivation changes
the levels of expression of host MP and thus the optical
characteristics of the membrane.)
To summarize, under the selective pressure of HtdR
expression, pHtdR400 has acquired one or several muta-
tions that significantly improve cell growth and func-
tional HtdR productivity, but do not increase the
accumulation of the MP on a per-cell basis as TF-inacti-
vation does.
Identification of the mutation and analysis of its effects
Plasmid pHtdR400 was sequenced to shed light on the
mechanism(s) responsible for the improvement in HtdR
productivity. We identified a single cytosine to adeno-
sine mutation located 98-nt from the transcription start
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Figure 2 Combining pHtdR400-based expression with the use of TF-deficient strains leads to large gain in HtdR productivity. (A)
Membrane fractions corresponding to identical numbers of cells were collected 3 h post-induction and analyzed for HtdR content by SDS-PAGE
(top) or immunoblotting (bottom) with anti-His antibodies. The arrow shows the migration position of HtdR while numbers below the blot
quantify the intensity of each band relative to an arbitrary value of 1 for control cells. (B) Influence of plasmid and genetic background on the
total yield of HtdR 3 h post-induction. (C) Absorption spectra of solubilized membranes isolated 3 h post-induction from the indicated cells.
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site of the PBAD promoter and mapping in a highly con-
served region of the 22 bp-long and symmetrical con-
sensus CRP binding site (Figure 3A, black arrow) [21].
To confirm that it was responsible for the improvement
in HtdR productivity, the transversion was introduced
into pHtdR200 via site directed mutagenesis. The
growth and HtdR expression patterns of wild type and
Δtig cells transformed with this plasmid (pHtdR400bis)
were indistinguishable from those of pHtdR400
transformants.
Because the mutation occurs near the primary kink of
the bended CRP-DNA complex [17] and affects a con-
tact with Glu181 [22] which is critical for CRP binding
[23,24] (Figure 3B), we suspected that it would affect
positive regulation and lead to a decrease in transcrip-
tion rates. To test this hypothesis, we used real-time
quantitative polymerase chain reaction (RT-qPCR) to
measure the relative levels of htdR mRNA in tig+ and
Δtig cells harboring either pHtdR200 or pHtdR400. Fig-
ure 3C shows that the mutation led to ≈ 65% reduction
in htdR transcript concentration irrespective of the
genetic background.
To further confirm that inefficient CRP binding was
responsible for the decrease in transcription rates, we
took advantage of the fact that the CRP homodimer
binds to a consensus sequence with twofold symmetry
and introduced a guanine to thymine mutation in the
opposite half-site of pHtdR200, in essence building the
counterpart of the spontaneous cytosine to adenine
mutation (Figure 3A, blue arrow). The resulting plasmid
(pHtdR401) was introduced into wild type and Δtig cells
and RT-qPCR experiments repeated. Figure 3C shows
that htdR mRNA levels produced from pHtdR401 were
virtually identical to those produced from pHtdR400 in
both genetic backgrounds.
In an argument similar to that invoked for explaining
the improved performance of C41(DE3) and C43(DE3)
strains [7], we conclude that the net reduction in
mRNA levels caused by inefficient CRP-dependent acti-
vation of the PBAD promoter decreases the flux of HtdR
to the inner membrane and alleviates Sec translocon
overloading by providing a better match between the
supply of incoming MPs and the insertional capacity at
the membrane. This in turns reduces toxicity, improves
cell growth, and leads to higher productivities.
It is also worth noting that a 2/3 reduction in htdR
transcription does not correlate with a net decrease in
the amount of membrane-integrated HtdR on a per-cell
basis (Figure 2A). We believe that this result is protein-
specific (see below) and that there is a “sweet spot” for
which the transcription rate of a target MP is well
matched with the rate at which the translocational
machinery can insert and/or fold this particular sub-
strate in the lipid bilayer.
Figure 3 Plasmid pHtdR400 carries a single nucleotide mutation
in the CRP binding site of the PBAD promoter that strongly
reduces htdR transcription. (A) Sequence logo [29] from the
alignment of 59 CRP binding sites [21,30]. The size of each nucleotide
is proportional to its degree of conservation. The black arrow shows
the location of the cytosine to adenosine mutation in pHtdR400. The
blue arrow shows the location of the guanine to thymine mutation
introduced in pHtdR401. (B) Ribbon structure of CRP bound to its
binding site rendered with Chimera using 1CGP coordinates [17]. The
box shows the proximity of Glu181 to the cytosine to adenosine
mutation (blue) in pHtdR400. (C) Relative mRNA levels were quantified
from the indicated cells 1 h post-induction.
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Reduced transcription and TF inactivation synergistically
improve Sensory Rhodopsin II production
To investigate whether the yield improvements observed
with HtdR could be generalized to other MPs, we con-
structed pBLN400 a derivative of our standard pBLN200
PBAD expression vector incorporating the cytosine to
adenosine mutation in its CRP binding site. We next
placed a different His-tagged rhodopsin, Natronobacter-
ium pharonis sensory rhodopsin II (pSRII) [25], under
control of the mutated promoter and transformed the
resulting plasmid (pPPR400) into both wild type and tig
null cells.
Consistent with what would be expected from a
weaker promoter, tig+ pPPR400 cells accumulated about
40% less pSRII in their membranes compared to
pPPR200 transformants (Figure 4B), but healthier cell
growth (Figure 4A, ■) led to nearly identical total yields
(Figure 4C). Also as expected [5], Δtig cultures produ-
cing pSRII from the standard PBAD promoter exhibited
improved growth (but not as much as tig+ pPPR400
cells; compare ■ and ○ in Figure 4A), higher levels of
membrane-integrated pSRII (Figure 4B) and over 2-fold
higher productivities relative to control cultures (Figure
4C). Expression of pSRII from the mutant promoter in
Δtig cells did not lead to a reduction in the amount of
membrane-integrated protein as it did in the wild type.
Rather, this combination caused a large improvement in
cell growth that translated into shake flask yields of 10
mg/L of culture and a more than 4-fold increase in
pSRII productivity relative to tig+ pPPR200 control cul-
tures (Figure 4). These results closely parallel those
obtained with HtdR and indicate that the productivity
ceiling that one reaches by decreasing transcription
rates can be shattered by combining it with chaperone
pathways reprogramming.
Conclusions
Downregulating gene transcription by decreasing the
intracellular levels of the highly processive T7 RNA
polymerase is a well-established approach to improve
the yields of MPs whose genes have been placed under
control of the bacteriophage T7 promoter. The bene-
fits have been explained by a harmonization of transla-
tion and membrane insertion which mitigates the
toxicity associated with Sec translocon saturation [4].
Here, we describe a single nucleotide mutation in one
of the conserved half-sites of the PBAD promoter’s CRP
binding region that improves the recovery yields of
active HtdR through a similar mechanism. However, as
illustrated with the closely related sensory rhodopsin
II, it is possible that improved cell growth only barely
compensates for reduced transcription, leading to
unchanged MP productivity (Figure 4D).
We recently reported that inactivation of TF is an
alternative means to alleviate MP toxicity, likely because
it allows signal recognition particle (SRP) unimpeded
access to nascent TMS emerging from the ribosome and
more efficient delivery of ribosome-nascent membrane
protein complexes to FtsY (the SRP receptor) which
delivers this cargo to the Sec translocon [5]. Here, we
further show that the use of Δtig cells can be combined
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Figure 4 Reduced transcription and TF-inactivation synergistically improve the yields of pSRII. (A) Wild type (tig+, closed symbols) and TF-
deficient cells (Δtig, open symbols) harboring the indicated plasmids were grown in LB-kanamycin at 37°C and pSRII synthesis was induced by
addition of 0.2% L-arabinose in mid-exponential phase (arrow). (B) Membrane fractions corresponding to identical numbers of cells were
collected 3 h post-induction and analyzed for pSRII content by SDS-PAGE (top) or immunoblotting (bottom) with anti-His antibodies. The arrow
shows the migration position of pSRII while numbers below the blot quantify the intensity of each band relative to an arbitrary value of 1 for
control cells. (C) Influence of plasmid and genetic background on the total yield of pSRII 3 h post-induction.
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synergistic gains in culture fitness and MP productivity.
Thus, how nascent MPs are delivered to the translocon
is probably as important as how many chains seek
engagement by the Sec machinery in determining
recombinant MP toxicity and their eventual yields.
Materials and methods
Strains, plasmids and culture conditions
E. coli BW25113 [Δ(araD-araB)567 ΔlacZ4787 (::rrnB-
3) l- rph-1 D(rhaD-rhaB)568, hsdR514] [26], KTD101
[BW25113 Δtig100] [20], and plasmid pHtdR200 [5]
have been described previously. KTD101(pHtdR200)
cells were grown to A600 ≈ 0.45 in 125 mL flasks con-
taining 25 mL of LB media supplemented with 50 μg/
mL kanamycin. Samples were streaked on LB agar
plates supplemented with 50 μg/mL kanamycin, 100
μM of all-trans retinal (Sigma; 10 mM stock solution
in methanol), and 0.2% L-arabinose and the plates
were incubated at 37°C for 36 h. A colony exhibiting
both larger size and pronounced purple color was iso-
lated, grown in LB-kanamycin and the plasmid was
purified. The regions of the plasmid corresponding to
the PBAD promoter and regulatory region, origin of
replication, araC gene and htdR gene were sequenced.
The mutant plasmid was named pHtdR400 and trans-
formed into chemically competent BW25113 and
KTD101. The single nucleotide mutation found in
pHtdR400 was introduced into pHtdR200 and
pBLN200 [5] by site-directed mutagenesis using pri-
mers 5’-CAAAGTGTGACGCCGTGAAAATAAT-
CAATGTGGAC-3 ’ and 5 ’-GTCCACAT
TGATTATTTTCACGGCG TCACACTTTG-3’, yield-
ing pHtdR400bis and pBLN400, respectively. This
mutation was also introduced into the opposite CRP
binding half-site of pBLN200 by site-directed mutagen-
esis using primers 5’-GCTATGGCATAGCAAAGTGT-
TACGCCGT GCAAATAATCAATG-3’ and 5 ’-
CATTGATTATTTGCACGGCGTAACACTTTGC-
TATGCCATAGC-3’ to generate pBLN401. The gene
encoding pSRII was excised from pPPR200 [5] using
NdeI and XhoI, and cloned into the same sites of
pBLN400 to create pPPR400. The gene encoding HtdR
from pHtdR200 was similarly subcloned into pBLN400
to create pHtdR401.
For viability experiments, culture tubes (18 mL) con-
taining 5 mL of LB supplemented with 50 μg/mL
kanamycin were inoculated with the indicated cells to
an A600 ≈ 0.05 and cells were grown at 37°C to A600 ≈
0.45. Samples were either streaked directly on LB-agar
plates supplemented with 50 μg/mL kanamycin, 0.4%
L-arabinose, and 10 μM of all-trans retinal, or diluted
in LB medium by factors of 10 and spotted on plates
in 10 μL aliquots.
Membrane protein expression, isolation and
characterization
HtdR and pSRII were expressed as previously described
[5]. Briefly, cells were grown at 37°C in 125 mL shake
flasks containing 25 mL of LB media supplemented
with 50 μg/mL kanamycin to mid-exponential phase
(A600 ≈ 0.45). Cultures were supplemented with all-
trans retinal to a 10 μM final concentration and MP
synthesis initiated by addition of 0.2% L-arabinose.
Cells (5 mL) were harvested 3 h post-induction, dis-
rupted with a French press operated at 10,000 psi, sub-
jected to centrifugation at 10,000 g for 10 min at 4°C
to remove aggregated material, and the supernatant
was centrifuged at 150,000 g for 1 h at 4°C to collect
membrane material. Samples corresponding to identi-
cal amounts of cells (based on A600) were analyzed by
SDS-PAGE and immunoblotting with anti-6-His anti-
bodies (Covance) as described [5]. To collect HtdR
adsorption spectra, membranes fractions prepared as
above were resuspended in 50 mM 2-(N-morpholino)
ethanesulfonic acid (MES), pH 6.5, 300 mM NaCl, 5
mM imidazole, and 1.0% n-dodecyl b-D-maltoside
(DDM) and spectra were acquired on a Beckman coul-
ter DU640 spectrophotometer.
Real-time RT-PCR
RNA was purified from cells grown and induced as
above and 1 h after induction of HtdR synthesis using
the Aurum Total RNA Mini Kit (BioRad). Total RNA
concentrations for each sample were estimated using
A260 measurements and 50 ng RNA was used as tem-
plate with the iScript One-Step RT-PCR Kit with SYBR
Green (BioRad). The reverse transcription (RT) of
mRNA encoding HtdR and real-time PCR reactions
were done with 8 replicates for each sample, and 16s
RNA as the internal standard. Primers 5’-GTGATCG-
GAAAATGCAGGAG-3’ and 5’-GCGATCGTGTTT
CGGTTCG-3’ were used to quantify mRNA encoding
HtdR. Primers 5’-GCCATAACGTCGCAAGACCAAAG-
3’ and 5’-TTCTTCATACACGCGGCATGG-3’ were
used for the 16s RNA standard [27]. Relative expression
levels were analyzed using the 2-ΔΔCT method [28].
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